Platinum(II) and copper(I) 1-(2-diphenylphosphino-1-naphthyl) isoquinoline complexes: Synthesis and phosphorescence at ambient conditions

The compounds Pt(quinap)(CN)₂, and [Cu(quinap)I]₂ with quinap = 1-(2-diphenylphosphino-1-naphthyl)isoquinoline were synthesized. Quinap is a bidentate ligand which contains a isoquinoline and an arylphosphine group with CT acceptor properties. Accordingly, the Pt(II) and Cu(I) quinap complexes are characterized by a phosphorescence originating from the lowest-energy MLCT triplets with some IL admixture.     

Structures and luminescence of mononuclear and dinuclear base-stabilized gold(I) pyrazolate complexes

The mono- and dinuclear base-stabilized gold(I) pyrazolate complexes, (PPh₃)Au(μ-3,5-Ph₂pz)) (1), (TPA)Au(3,5-Ph₂pz), TPA=1,3,5-triaza-7-phophaadamantane (2), [(PPh₃)₂Au(μ-3,5-Ph₂pz)]NO₃ (3) and [(dppp)Au(μ-3,5-Ph₂pz)]NO₃, dppp=bis(diphenylphosphino)propane (4), have been synthesized and structurally characterized. The mononuclear gold(I) complexes 1 and 2 show intermolecular Au?Au interactions of 3.1540(6) and 3.092(6) Å, while the dinuclear gold(I) complexes 3 and 4 show an intramolecular Au?Au distances of 3.3519(7) and 3.109(2) Å, respectively, typical of an aurophilic attraction. Complexes 1-4 exhibit luminescence at 77 K when excited with ca. 333 nm UV light with an emission maximum at ca. 454 nm. The emission has been assigned to ligand-to-metal charge transfer, LMCT, based upon the vibronic structure that is observed.     

Heteroleptic Cu(I) complexes containing phenanthroline-type and 1,1′-bis(diphenylphosphino)ferrocene ligands: Structure and electronic properties

Three new heteroleptic Cu(I) complexes containing one phenanthroline and one diphosphine type ligand ([Cu(N-N)(P-P)]⁺) have been prepared. In particular, one ligand is constituted by 1,10-phenanthroline (1), 2,9-dimethyl-1,10-phenanthroline (2) and 2,9-diphenethyl-1,10-phenanthroline (3) and the other ligand is in all cases 1,1′-bis(diphenylphosphino)ferrocene (dppf). Therefore, copper and iron metal centres are quite close one another, as evidenced by X-ray crystal diffraction. The structure together with the electrochemical and photophysical properties of these complexes have been compared to that of the corresponding complexes where dppf has been replaced by bis[2-(diphenylphosphino)-phenyl]ether (POP). Cyclic voltammetric experiments evidenced that the first oxidation process is located on the ferrocene moiety and that oxidation of Cu(I) is moved to more positive potential values and a chemical reaction is coupled to the electron transfer process. The absorption spectra show a metal-to-ligand charge transfer (MLCT) band, typical of Cu(I) phenanthroline complexes, at a higher energy compared to the homoleptic [Cu(N-N)₂]⁺ species. No emission at either room temperature or 77 K has been observed for compounds 2 and 3, contrary to the high luminescence observed for the corresponding POP complexes. This result is consistent with a photoinduced energy transfer from the Cu(I) complex to the ferrocene moiety.     

Non-innocent ligand reservoirs for reducing or oxidizing equivalents in carbonylrhenium(I) complexes: 1,1′-Bis(diphenylphosphino)ferrocene (dppf) and bis-triazinyl-pyridine (BTP)

Organometallic complexes of Re(I) with ligands having opposite redox properties have been synthesized and structurally characterized. X-ray crystal structures of the complexes show typical fac-Re^I(CO)₃ coordination to the redox active ligands. Complete electrochemical and spectroelectrochemical studies on the ligands and the metal complexes were performed. The IR-spectroelectrochemical responses were monitored using the fac-Re(CO)₃ unit as a probe. The 15-20 cm⁻¹ hypsochromic or bathochromic shift of the ν_CO bands upon reduction or oxidation is attributed to ligand-centered processes.     

In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake

In this study we characterised the in vitro antitumour and hepatotoxicity profiles of a series of Au(I) and Ag(I) bidentate phenyl and pyridyl complexes in a panel of cisplatin-resistant human ovarian cancer cell-lines, and in isolated rat hepatocytes. The gold and silver compounds overcame cisplatin-resistance in the CH1-cisR, 41M-cisR and SKOV-3 cell-lines, and showed cytotoxic potencies strongly correlated with their lipophilicity. Complexes with phenyl or 2-pyridyl ligands had high antitumour and hepatotoxic potency and low selectivity between different cell-lines. Their cytotoxicity profiles were similar to classic mitochondrial poisons and an example of this type of compound was shown to accumulate preferentially in the mitochondria of cancer cells in a manner that depended upon the mitochondrial membrane potential. In contrast, complexes with 3- or 4-pyridyl ligands had low antitumour and hepatotoxic potency and cytotoxicity profiles similar to 2-deoxy-D-glucose. In addition, they showed high selectivity between different cell-lines that was not attributable to variation in uptake in different cell-types. The in vitro hepatotoxic potency of the series of gold and silver compounds varied by over 61-fold and was closely related to their lipophilicity and hepatocyte uptake. In conclusion, Au(I) and Ag(I) bidendate pyridyl phosphine complexes demonstrate activity against cisplatin-resistant human cancer cells and in vitro cytotoxicity that strongly depends upon their lipophilicity.     

In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands

Hydrophilic, monocationic [M(L)₄]PF₆ complexes (M = Cu or Ag; L: thp = tris(hydroxymethyl)phosphine, L: PTA = 1,3,5-triaza-7-phosphaadamantane, L: thpp = tris(hydroxypropyl)phosphine) were synthesized by ligand exchange reaction starting from [Cu(CH₃CN)₄]PF₆ or AgPF₆ precursors at room temperature in the presence of an excess of the relevant phosphine. The related [Au(L)₄]PF₆ complexes (L = thp, PTA or thpp) were synthesized by metathesis reactions starting from [Au(L)₄]Cl at room temperature in the presence of equimolar quantity of TlPF₆. The three series of complexes [M(L)₄]PF₆ were tested as cytotoxic agents against a panel of several human tumour cell lines also including a defined cisplatin resistant cell line. These investigations have been carried out in comparison with the clinically used metallodrug cisplatin and preliminary structure-activity relationships are presented. The best results in terms of in vitro antitumour activity were achieved with metal-thp species and, among the coinage metal complexes, copper derivatives were found to be the most efficient drugs. Preliminary studies concerning the mechanism of action of these [M(L)₄]PF₆ species pointed to thioredoxin reductase as one of the putative cellular targets of gold and silver complexes and provided evidence that copper derivatives mediated their cytotoxic effect through proteasome inhibition.     

Proton-linked bi- and tri-metallic gold cyanide complexes observed by ESI-MS spectrometry

Electrospray ionization spectra of potential cyanide-containing gold-drug metabolites revealed additional, weak, unanticipated peaks at approximately twice the mass of the gold(I) and gold(III) cyanide complexes. The exact masses correspond to proton-linked bimetallic complexes, [H[Au(CN)(m)](2)](-), (m=2,4). Further investigation revealed a total of 12 examples, including trimetallic complexes, [H(2)[Au(CN)(m)](3)](-); mixed species with two complexes, [H[Au(CN)(2)][Au(CN)(4)]](-); and thiolato species, [H[(RS)Au(CN)(3)](2)](-). trans-[AuX(2)(CN)(2)Cl(2)](-) and trans-[AuX(2)(CN)(2)Br(2)](-) generated (35)Cl/(37)Cl and (79)Br/(81)Br isotopic patterns for the protonated bi- and tri-metallic analogues which were in good agreement with the presence of four or six halide ligands, respectively. Concentration-dependent studies demonstrated that the signals are independent of the solution concentrations of mono-metallic precursors, suggesting formation in the gas phase during or following droplet desolvation.     

Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma

The effects of square planar rhodium, [RhacacCOD]o and iridium, [IracacCOD]o complexes and of octahedral ruthenium, [cis-RuCl2 (DMSO)4]o complex have been examined in comparison with cis-dichlorodiammino platinum(II) (cis-PDD). The toxicity in BDF1 mice varies widely and decreasing LD50-values, ranging from 0.94 mg/kg to 1000 mg/kg, have been obtained for cis-PDD, [RhacacCOD]o, [IracacCOD]o and [cis-RuCl2(DMSO)4]o, respectively. All the tested complexes similarly inhibit the growth of subcutaneous Lewis lung carcinoma and the development of spontaneous as well as of artificial metastases, with the exception of [IracacCOD]o which is inactive on metastases. The antitumor activity of [RhacacCOD]o and [cis-RuCl2(DMSO)4]o appears interesting, since it is of the same magnitude as that of cis-PDD, considering also that they were found to be only marginally nephrotoxic.     

Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity

Complexes [Au(H2Ac4DH)Cl]?MeOH (1) [Au(H₂2Ac4Me)Cl]Cl (2) [Au(H₂2Ac4Ph)Cl]Cl?2H₂O (3) and [Au(H₂2Bz4Ph)Cl]Cl (4) were obtained with 2-acetylpyridine thiosemicarbazone (H2Ac4DH), its N(4)-methyl (H2Ac4Me) and N(4)-phenyl (H2Ac4Ph) derivatives, as well as with N(4)-phenyl 2-benzoylpyridine thiosemicarbazone (H2Bz4Ph). The compounds were cytotoxic to Jurkat (immortalized line of T lymphocyte), HL-60 (acute myeloid leukemia), MCF-7 (human breast adenocarcinoma) and HCT-116 (colorectal carcinoma) tumor cell lines. Jurkat and HL-60 cells were more sensitive than MCF-7 and HCT-116 cells. Upon coordinating to the gold(I) metal centers in complexes (2) and (4), the cytotoxic activity of the H2Ac4Me and H2Bz4Ph ligands increased against the HL-60 and Jurkat tumor cell lines. 2 was more active than auranofin against both leukemia cells. Most of the studied compounds were less toxic than auranofin to peripheral blood mononuclear cells (PBMC). All compounds induced DNA fragmentation in HL-60 and Jurkat cells indicating their pro-apoptotic potential. Complex (2) strongly inhibited the activity of thioredoxin reductase (TrxR), which suggests inhibition of TrxR to be part of its mechanism of action.     

Syntheses, crystal structures, and characterization of heteronuclear complexes based on a versatile ligand with both acetylacetonate and bis(2-pyridyl) units

A new type of multidentate ligand with both acetylacetonate and bis(2-pyridyl) units on the 1,3-dithiole moiety, 3-[2-(dipyridin-2-yl-methylene)-5-methylsulfanyl-[1,3]dithiol-4-ylsulfanyl]-pentane-2, 4-dione (L), has been prepared. Through reactions of the ligand with Re(CO)₅X (X = Cl, Br), new rhenium(I) tricarbonyl complexes ClRe(CO)₃(L) (2) and BrRe(CO)₃(L) (3), have been obtained. With the use of 2 or 3 as the precursors, the further reactions with (Tp^Ph2)Co(OAc)(Hpz^Ph2) (Tp^Ph2 = hydrotris(3,5-diphenylpyrazol-1-yl)borate); Hpz^Ph2 = 3,5-diphenyl-pyrazole) or M(OAc)₂(M = Mn, Zn), afford four new heteronuclear complexes: ClRe(CO)₃(L)Co(Tp^Ph2) (4), BrRe(CO)₃(L)Co(Tp^Ph2) (5), [ClRe(CO)₃(L)]₂Mn(CH₃OH)₂ (6) and [ClRe(CO)₃(L)]₂Zn(CH₃OH)₂ (7), respectively. Crystal structures of complexes 2 and 4-7 have been determined by X-ray diffraction. Their absorption spectra, photoluminescence and magnetic properties have been studied.     

Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl)dithioacetate ligand

Copper(I) complexes have been synthesized from the reaction of CuCl, monodentate tertiary phosphines PR₃ (PR₃ = P(C₆H₅)₃; P(C₆H₅)₂(4-C₆H₄COOH); P(C₆H₅)₂(2-C₆H₄COOH); PTA, 1,3,5-triaza-7-phosphaadamantane; P(CH₂OH)₃, tris(hydroxymethyl)phosphine) and lithium bis(3,5-dimethylpyrazolyl)dithioacetate, Li[LCS₂]. Mono-nuclear complexes of the type [LCS₂]Cu[PR₃] have been obtained and characterized by elemental analyses, FT-IR, ESI-MS and multinuclear (¹H, ¹³C and ³¹P) NMR spectral data; in these complexes the ligand behaves as a κ³-N,N,S scorpionate system. One exception to this stoichiometry was observed in the complex [LCS₂]Cu[P(CH₂OH)₃]₂, where two phosphine co-ligands are coordinated to the copper(I) centre. The solid-state X-ray crystal structure of [LCS₂]Cu[P(C₆H₅)₃] has been determined. The [LCS₂]Cu[P(C₆H₅)₃] complex has a pseudo tetrahedral copper site where the bis(3,5-dimethylpyrazolyl)dithioacetate ligand acts as a κ³-N,N,S donor.     

Synthesis and crystal structures of mono- and dinuclear silver(I) complexes bearing 1,8-naphthyridine ligand

Mononuclear and dinuclear silver(I) complexes bearing 1,8-naphthyridine (napy) were prepared. The crystal structures of [Ag(napy-κN)₂](PF₆) (1) and [Ag₂(μ-napy)₂](PF₆)₂ · 3CH₃CN (2 · 3CH₃CN) were determined by X-ray diffraction studies. In complex 1, intermolecular π-π interaction of napy ligands between neighboring molecules forms left-handed hexagonal columns in the solid state. On the other hand, two napy ligands bridging two Ag ions in the dinuclear complex 2 shape a face-to-face π-π stacking with those of the neighboring molecule to form the dimeric unit. Besides, two of four napy ligands, which are located in a diagonal position in the dimeric unit, build intermolecular back-to-back π-π stackings with those of the adjacent dimeric unit, and a ladder-like stairway structure is generated in the solid state. Irrespective of such characteristic structures of 1 and 2 in the solid state, both complexes show very rapid dynamic behavior in solutions. No conversion between 1 and 2 took place even in the presence of excess amounts of Ag⁺ or napy in solutions.     

Two new mononuclear gold(I)-nitrogen [N,N′-di(2,6-methyl)phenylformamidine] complexes: Syntheses and crystal structures

Two gold(I) mononuclear complexes have been prepared by reacting gold(I) tetrahydrothiophene with N,N′-di(2,6-methyl)phenylformamidine. The neutral complex [N,N′-di(2,6-methyl)phenylformamidine)-gold(I) chloride (C₁₇H₂₀AuClN₂) (1), crystallizes in the triclinic group while the cationic [N,N′-di(2,6-methyl)phenylformamidine](tetrahydrothiophene)-gold(I) (C₂₁H₂₈AuN₂S) (2) crystallizes with a nitrate anion in the monoclinic group P2(1)/n. Both compounds are good starting materials for synthetic gold chemistry.     

Synthesis and in vitro evaluation of gold(I) thiosemicarbazone complexes for antimalarial activity

The reaction of thiosemicarbazones (TSCs) with [Au^I(THT)Cl], THT = tetrahydrothiophene, has been investigated. The resulting gold(I) complexes have been characterized by a range of spectroscopic techniques: NMR spectroscopy, mass spectrometry, microanalysis and infrared spectroscopy. The in vitro antimalarial data for gold(I) TSC complexes suggests that coordination of gold(I) to TSCs enhanced their efficacy against the malaria parasite Plasmodium falciparum and their inhibition of the parasite cysteine protease falcipain-2.     

Ethylenediamine- and propylenediaminediacetic acid derivatives as ligands for the “fac-[M(CO)3]” core (M = Re, Tc)

The reaction of Re(CO)₅Cl with o- or p-N-(nitrophenyl)ethylenediaminediacetic acid (H₂L¹, H₂L²) and o- or p-N-(nitrophenyl)propylenediaminediacetic acid (H₂L³, H₂L⁴) in methanol leads to the formation of stable anionic [Et₃NH][Re(CO)₃(L)] · H₂O complexes 1-4. These compounds have been characterized by means of IR, mass spectrometry, elemental analysis, NMR and conductimetry, as well as X-ray crystallography for 2 and 3. The [Re(CO)₃]⁺ moiety is coordinated via the nitrogen of the iminodiacetic acid unit and two oxygens of monodentate carboxylate groups. In each case, the nitro group of the aromatic ring remains uncoordinated. The analogous technetium-99m complexes 1′ and 3′ were also prepared quantitatively by the reaction of H₂L¹ and H₂L³, respectively, with the fac-[^99mTc(CO)₃(H₂O)₃]⁺ precursor in ethanol. The corresponding Re and ^99mTc compounds were shown to possess the same structure by means of HPLC studies. The high affinity of these ligands for the Tc(I) or Re(I) core, coupled with the easiness of their derivatization (by reduction of the nitro group in amino group), implies that the utilization of this ligand system to develop target-specific radiopharmaceuticals for diagnosis and therapy is promising.     

The synthesis, structure, and luminescence of two silver(I)-dppm complexes based on sulfate anion and nitrogen heterocyclic ligands

At ambient temperature, two silver(I) complexes [Ag₄(SO₄)₂(dppm)₄]·5CH₃CH₂OH·1/2H₂O (1) and [Ag₂(SO₄)(dppm)₂(2-ampz)]·CH₃OH·H₂O (2) (dppm = bis(diphenylphosphino)methane, 2-ampz = 2-aminopyrazine) were obtained by the reaction of Ag₂SO₄ with dppm in the presence of pyrazine or 2-aminopyrazine. They are characterized by IR, X-ray crystallography, luminescence and ¹H, ³¹P NMR spectroscopy. Complex 1 is a tetranuclear cluster. In complex 2, the units [Ag₂(SO₄)(dppm)₂] are connected by 2-aminopyrazine to form a 1D linear polymer. Due to the subtle interactions of different nitrogen heterocyclic ligands with silver ions, two SO₄²⁻ anions in 1 adopt μ₃-O, O′, O′ and unique μ₄-O, O, O′, O′ bonding modes respectively, while SO₄²⁻ anion in 2 adopts μ-O, O′ bonding mode.     

Nickel(II) and iron(II) mononuclear complexes with 1-methylimidazole-2-aldoximate: New building units for molecule-assembled magnetic materials

A new class of mononuclear metal complexes with 1-methylimidazole-2-aldoximate (miao) has been synthesized and characterized: trans-Ni^II(Cl)₂(Hmiao)₂ (1), trans-Ni^II(miao)₂(py)₂ (2), NO-trans-Ni^II(miao)₂(phen) (3), and NO-trans-Fe^II(miao)₂(phen) (4). The crystal structures of 2, 3, and 4 have been determined by single-crystal X-ray crystallography. Compound 1 having the protonated miao ligand (i.e., Hmiao) is a precursor for synthesizing 2 and 3. Compound 2 is an octahedral Ni^II complex surrounded by two miao bidentate ligands and two monodentate ligands of pyridine in a trans-arrangement. Compound 3 is a cis-type octahedral Ni^II complex with two miao ligands and a bidentate ligand of 1,10-phenanthroline, in which the ligand arrangement around Ni^II center is found in an NO-trans form. Compound 4 is an isostructural Fe^II derivative of 3. Compounds 1, 2, and 3 exhibit paramagnetic nature with an S = 1 spin and a positive zero-field splitting, among which it for 3 is overlapped with intermolecular ferromagnetic interaction (zJ/k_B = +0.16 K). Compound 4 is diamagnetic due to the existence of low-spin Fe^II ion.     

Synthesis, characterization, and crystal structures of hydrotris(2-mercapto-1-imidazolyl)borate-based zinc(II) and copper(I) complexes

The reaction of the tripod ligand hydrotris(2-mercapto-1-imidazolyl)borate Tm^xylyl with zinc(II) perchlorate in methanol afforded the mononuclear complex of the type [Tm^xylyl-Zn(mim^xylyl)]ClO₄ (1). Whereas under the same conditions, the reaction with copper(II) perchlorate gives rise to the simultaneous formation of the dinuclear copper(I) complex [Tm^xylylCu]₂ (2). The chemical formulae of the complexes have been characterized by elemental chemical analysis, IR-NMR spectroscopies, and single crystal X-ray methods. In complex 1, the zinc(II) atom displays a distorted tetrahedral environment. While in complex 2, the Tm^xylyl ligand bridges the two copper(I) atoms in an asymmetric manner with trigonal geometry. The inverted conformation of the ligand Tm^xylyl at the boron center, allows the B-H units to be directed towards the copper centers. The greater reactivity of the borohydride groups towards metal centers enhances the reduction of Cu(II) to Cu(I). The obtained kinetic results for the methylation reactions of 1 and 2 indicate that these bound thione complexes are less suitable to electrophilic attack than the thiolate ligand.     

Homo- and heteronuclear complexes based on arene ruthenium complexes bearing bis(diphenylphosphinomethyl)phenylphosphine (dpmp)

Reactions of [(p-cymene)RuCl₂]₂ (1a) with dpmp ((Ph₂PCH₂)₂PPh) in the absence or presence of KPF₆ afforded the ionic complexes [{(p-cymene)RuCl₂}(dpmp-P¹,P³;P²){RuCl(p-cymene)}](X) (2a₁: X=Cl; 2a₂: X=PF₆). A (p-cymene)RuCl moiety constructs a 6-membered ring coordinated by two terminal P atoms of the dpmp ligand and another one binds to a central P atom of the ligand. Reactions of [(C₆Me₆)RuCl₂]₂ (1b) with an excess of dpmp in the presence of KPF₆ gave a 4-membered complex [(C₆Me₆)RuCl(dpmp-P¹,P²)](PF₆) (3b), chelated by a terminal and a central P atom and another terminal atom is free. Use of Ag(OTf) instead of KPF₆ gave [{(C₆Me₆)RuCl₂(dpmp)Ag} ₂](OTf)₂ (5b) that the Ag atoms were coordinated by a terminal and a central P atom of each dpmp ligand. Reaction with an equivalent of dpmp in the presence of KPF₆ gave [{(C₆Me₆)RuCl}(dpmp-P¹,P²;P³){(C₆Me₆)RuCl₂}](PF₆) 4b. Complex has a structure that the (C₆Me₆)RuCl₂ moiety coordinated to the free P atom of 3b. Complex 3b was treated with MCl₂(cod) (M=Pd, Pt), [Pd(MesNC)₄](PF₆)₂ (MesNC=2,4,6-Me₃C₆H₂NC) or [Pt₂(XylNC)₆](PF₆)₂ (XylNC=2,6-Me₂C₆H₃NC), generating [{(C₆Me₆)RuCl(dpmp)}₂MCl₂](PF₆)₂ (8b: M=Pd; 9b: M=Pt), [{(C₆Me₆)RuCl(dpmp)}₂{Pt(MesNC)₂}](PF₆)₄ (10b) and [{(C₆Me₆)RuCl(dpmp)}₂{Pt₂(XylNC)₄}](PF₆)₄ (11b), respectively. Complex 3b reacted readily with [Cp*MCl₂]₂ (M=Rh, Ir) or AuCl(SC₄H₈), affording the corresponding hetero-binuclear complexes [{(C₆Me₆)RuCl}(dpmp-P¹,P²;P³)(MCl₂Cp^*](PF₆) (6b: M=Rh; 7b: M=Ir) and [{(C₆Me₆)RuCl}(dpmp-P¹,P²;P³)(AuCl)](PF₆) (12b). These complexes have two chiral centers. Some complexes were separated as two diastereomers by successive recrystallization. The structures of 3b, 5b, 6b, 8b and 12b were confirmed by X-ray analyses.